Iovance Biotherapeutics, Inc.

Overview

Iovance Biotherapeutics, Inc. is a commercial-stage biopharmaceutical company based in San Carlos, California. Founded in 2007, the company specializes in the development of tumor infiltrating lymphocyte (TIL) therapies designed to harness the immune system against solid tumor cancers, with particular focus on metastatic melanoma. Its approach aims to establish TIL therapies as a global standard of care by emphasizing innovation and a patient-centric focus.

The core platform utilizes autologous TIL therapy, extracting TIL cells from a patient’s tumor, expanding them in a laboratory environment, and reinfusing the cells to target cancer neoantigens. Approved products include Amtagvi (lifileucel) for unresectable or metastatic melanoma and Proleukin for metastatic melanoma and renal cell carcinoma. The company is advancing additional candidates in its pipeline for cancers such as cervical and non-small cell lung cancer, operates a GMP manufacturing facility in Philadelphia, and partners with leading institutions for clinical research.

Basic Information

Contact Details

• Phone: +1 650-260-7120
• Website: iovance.com
• LinkedIn: linkedin.com/company/iovance

Key Focus Areas & Initiatives

• Immuno oncology
• Autologous cell therapy
• Tumor infiltrating lymphocytes
• Novel cancer immunotherapies
• Cell therapy
• Biotechnology: biological products (no diagnostic substances)
• Health care
• Biotechnology research
• Tumor neoantigen targeting
• Personalized immunotherapy
• Cancer treatment platform
• TIL manufacturing technology
• Personalized cancer therapy
• Immune system harnessing
• Biotech clinical development
• Cancer treatment innovation
• Cancer treatment development
• Biotech leadership
• Personalized cancer vaccines
• Clinical-stage biopharmaceutical
• Biotech innovation
• Clinical trial enrollment
• Tumor-specific neoantigens
• Oncology
• Cell therapy platform
• Broad neoantigen recognition
• Biotech development
• Immune cell recognition
• Solid tumor therapies
• Pharmaceuticals
• Personalized cancer treatment
• Blood cancer treatment
• Clinical research in oncology
• Medical research
• Patient-specific therapy
• Advanced solid tumor treatment
• Cell therapy manufacturing
• Clinical trials
• Biotech clinical trials
• Oncology treatment
• TIL monotherapy
• Cell therapy manufacturing process
• Immune cell reinfusion
• Neoantigen targeting
• Neoantigen recognition
• Cancer clinical pipeline
• Immune response enhancement
• Biopharmaceutical innovation
• Cancer therapy pipeline
• Biopharmaceutical
• Clinical-stage biotech
• TIL manufacturing
• Biotech company leadership
• Personalized cell therapy
• Biotech manufacturing
• Lifileucel
• Oncology biotech
• Manufacturing process
• Solid tumor treatment
• Cancer immunology
• FDA accelerated approval
• Genetically modified TIL
• Biotech research
• Immune response
• Cancer pipeline
• Biotechnology
• Melanoma treatment
• Tumor-infiltrating lymphocytes
• Oncology clinical development
• Immune system activation
• Oncology research
• Research and development in the physical, engineering, and life sciences
• Cancer immunotherapy
• Blood cancer therapy
• Cancer immunotherapy research
• Immune cell therapy
• Personalized medicine
• Next-generation cell therapy
• Cancer cell recognition
• TIL therapy
• FDA approval
• Clinical research
• Next-generation therapies
• Ex vivo T cell expansion
• Cell therapy research
• Combination cancer therapies
• T-cell therapy
• Cancer treatment
• Immunotherapy
• Solid tumors
• PBL therapy
• Autologous therapy
• Advanced solid tumors
• Neoplasms
• Neoantigens
• Chronic lymphocytic leukemia
• Small lymphocytic lymphoma
• Melanoma
• Non-small cell lung cancer
• Gynecologic cancers
• Interleukin-2
• Lymphodepleting chemotherapy
• Tumor markers
• Cell banking
• Cryopreservation
• Good manufacturing practices
• FDA compliance
• Cancer vaccines
• Combination therapies
• Investigational agents
• Cell therapy center
• Cancer biomarkers
• Scientific publications
• Innovative therapies
• Biopharmaceutical industry
• Translational medicine
• Biological therapies
• Quality assurance
• Patient recruitment
• Drug development
• Therapy deployment
• Detecting cancer
• Biomedical ethics
• Healthcare compliance
• Personalized therapy
• Therapeutic targets
• Therapy innovation
• Healthcare
• Manufacturing
• Health, wellness & fitness
• Hospital & health care
• Medical
• Mechanical or industrial engineering

Technologies Used

• .NET
• AI
• AMP
• ARES
• Amazon AWS
• Amazon CloudFront
• CONTROL
• Carbon
• Emerson Syncade
• Flow
• Gem
• Google AdWords Conversion
• Google Tag Manager
• Greenhouse.io
• Inventor
• Liquid
• Microsoft 365
• Microsoft Excel
• Microsoft Office
• Microsoft Office 365
• Microsoft PowerPoint
• Mimecast
• Mobile Friendly
• Nitrogen
• Outlook
• Remote
• Route 53
• SAP Crystal Reports
• SQL
• Salesforce
• ServiceNow
• Slack
• Tor
• enablon